Hao Liu

Dr. Hao Liu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
TZTang Zhang
Tang Zhang
YGYao-Zong Guan
Yao-Zong Guan
HLHao Liu
Hao Liu
Acute myocardial infarction (AMI) is a leading cause of death and not a few of these patients are combined with acidemia. This study aimed to detect the association of acidemia with short-term mortality of AMI patients. A total of 972 AMI patients were selected from the Medical Information Mart for Intensive Care (MIMIC) III database for analysis. Propensity-score matching (PSM) was used to reduce the imbalance. Kaplan-Meier survival analysis was used to compare the mortality, and Cox-proportional hazards model was used to detect related factors associated with mortality. After PSM, a total of 345 non-acidemia patients and 345 matched acidemia patients were included. The non-acidemia patients had a significantly lower 30-day mortality (20.0% vs. 28.7%) and lower 90-day mortality (24.9% vs. 31.9%) than the acidemia patients (P < 0.001 for all). The severe-acidemia patients (PH < 7.25) had the highest 30-day mortality (52.6%) and 90-day mortality (53.9%) than non-acidemia patients and mild-acidemia (7.25 ≤ PH < 7.35) patients (P < 0.001). In Cox-proportional hazards model, acidemia was associated with improved 30-day mortality (HR = 1.518; 95%CI = 1.110-2.076, P = 0.009) and 90-day mortality (HR = 1.378; 95%CI = 1.034 -1.837, P = 0.029). These results suggest that severe acidemia is associated with improved 30-day mortality and 90-day mortality of AMI patients.

6 October 2022 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
RLRong‐Guang Lu
Rong‐Guang Lu
SLShuang‐Shuang Li
Shuang‐Shuang Li
BHBo Hu
Bo Hu
HLHong-Ye Li
Hong-Ye Li
HTHong Tian
Hong Tian
XBXue Bai
Xue Bai
A novel neurological disorder, shaking mink syndrome (SMS), emerged in Denmark and Sweden in 2000. SMS has seldom been reported in China, but the causative agent has not been detected in the country. SMS outbreaks occurred in multiple provinces in 2020. A total of 44 brain samples from minks associated with SMS were collected from Heilongjiang, Liaoning and Shandong provinces of which 28 samples (63.3%) were SMS-astrovirus (SMS-AstV)-positive by reverse transcription PCR. Histopathological examination revealed non-suppurative encephalitis in three minks. Moreover, the complete coding region sequences (CDSs, 6559 bp) of a sample collected from a 2-month-old mink (termed SMS-AstV-H1, GSA accession No. SAMC816786) were amplified by PCR and Sanger sequencing. The complete CDS and open reading frame 2 sequences of SMS-AstV-H1 were 94.3% and 96.4% identical to an SMS-AstV strain (GenBank accession number: GU985458). Phylogenetically, SMS-AstV-H1 was closely related to an SMS-AstV strain (GU985458). Based on the above results, we describe SMS-AstV-associated encephalitis in farmed minks in China. Future studies need to focus on epidemiology, virus isolation and potential interspecies transmission of SMS-AstV.

8 November 2022 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
YGYao-Zong Guan
Yao-Zong Guan
HLHao Liu
Hao Liu
HHHuan-Jie Huang
Huan-Jie Huang
DLDong-Yan Liang
Dong-Yan Liang
SWSi-Ying Wu
Si-Ying Wu
TZTang Zhang
Tang Zhang
Background. Transforming growth factor beta-induced protein (TGFBI, encoded by TGFBI gene), is an extracellular matrix protein, widely expressed in variety of tissues. It binds to collagens type I, II, and IV and plays important roles in the interactions of cell with cell, collagen, and matrix. It has been reported to be associated with myocardial fibrosis, and the latter is an important pathophysiologyical basis of atrial fibrillation (AF). However, the mechanism of TGFBI in AF remains unclear. We aimed to detect the potential mechanism of TGFBI in AF via bioinformatics analysis. Methods. The microarray dataset of GSE115574 was examined to detect the genes coexpressed with TGFBI from 14 left atrial tissue samples of AF patients. TGFBI coexpression genes were then screened using the R package. Using online analytical tools, we determined the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, Gene Ontology (GO) annotation, and protein-protein interaction (PPI) network of TGFBI and its coexpression genes. The modules and hub genes of the PPI-network were then identified. Another dataset, GSE79768 was examined to verify the hub genes. DrugBank was used to detect the potential target drugs. Results. In GSE115574 dataset, a total of 1818 coexpression genes (769 positive and 1049 negative) were identified, enriched in 120 biological processes (BP), 38 cellular components (CC), 36 molecular functions (MF), and 39 KEGG pathways. A PPI-network with average 12.2-degree nodes was constructed. The genes clustered in the top module constructed from this network mainly play a role in PI3K-Akt signaling pathway, viral myocarditis, inflammatory bowel disease, and platelet activation. CXCL12, C3, FN1, COL1A2, ACTB, VCAM1, and MMP2 were identified and finally verified as the hub genes, mainly enriched in pathways like leukocyte transendothelial migration, PI3K-Akt signaling pathway, viral myocarditis, rheumatoid arthritis, and platelet activation. Pegcetacoplan, ocriplasmin, and carvedilol were the potential target drugs. Conclusions. We used microdataset to identify the potential functions and mechanisms of the TGFBI and its coexpression genes in AF patients. Our findings suggest that CXCL12, C3, FN1, COL1A2, ACTB, VCAM1, and MMP2 may be the hub genes.

1 January 2024 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
TZTang Zhang
Tang Zhang
LGLinjuan Guo
Linjuan Guo
SLShucheng Liang
Shucheng Liang
HLHao Liu
Hao Liu
Direct oral anticoagulants (DOACs) are becoming increasingly popular clinically, but their safety and effectiveness profile in patients with chronic thromboembolic pulmonary hypertension (CTEPH) is not well-established. Literature from the PubMed and EMBASE databases was systematically screened up to February 2024 to identify relevant studies on the use of DOACs in CTEPH patients. The bias risk of RCTs was assessed using the Cochrane Risk of Bias Tool 2.0. The quality of observational prospective cohorts was assessed using the Newcastle-Ottawa Scale tool. Data pooled from different studies were analyzed. Results from 4 studies were gathered, including 2 randomized controlled trials and 2 prospective cohorts, with a total of 2038 patients, of which 751 were on DOACs and 1287 were on vitamin K antagonists (VKAs). Similar rates of all-cause mortality (3.33% vs 3.33%, RD = −0.01%, 95% CI [−0.02%, 0.00%], P = .17), VTE recurrence (1.46% vs 2.12%, RD = −0.00%, 95% CI [−0.01%, 0.01%], P = .92) were observed. DOACs were associated with a nonsignificant reduction in bleeding events including major bleeding (2.22% vs 3.71%, RD = −0.01%, 95% CI [−0.04%, 0.01%], P = .30), any bleeding (5.33% vs 9.94%, RD = −0.03%, 95% CI [−0.07%, 0.01%], P = .10), and minor bleeding (4.17% vs 13.3%, RD = −0.06%, 95% CI [−0.23%, 0.10%], P = .45). Data pooled from existing perspective trials suggests the use of DOACs in CTEPH patients as an effective and safe alternative to VKAs.

27 July 2020 in Research Square
Verified
Preprint
Open access
PDF file
TZTang Zhang
Tang Zhang
YGYao-Zong Guan
Yao-Zong Guan
HLHao Liu
Hao Liu
Background:The study aimed to detect the shared differentially expressed genes (DEGs) and specific DEGs of arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) as well as their pathways. Methods: The GSE29819 dataset was examined for the DEGs of ARVC vs. non-failing transplant donor hearts (NF), DCM vs. NF, and ARVC vs. DCM based on 8 patients with ARVC, 7 patients with DCM, and 4 non-failing transplant donor hearts that were never actually transplanted. The shared DEGs and specific DEGs were screened out using a Venn diagram. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, Gene Ontology (GO) annotation, and protein-protein interaction (PPI) of the DEGs were determined using online analytical tools. Then, the modules and hub genes were identified using Cytoscape software. Results: A total of 684 shared DEGs of ARVC vs. NF and DCM vs. NF, 1371 specific DEGs of ARVC vs. NF, and 1075 specific DEGs of DCM vs. NF were identified. The shared DEGs were enriched in 63 biological processes (BP), 11 molecular functions (MF), 10 cellular components (CC), and 25 KEGG pathways. The DEGs of ARVC vs. DCM were enriched in 71 BPs, 19 MFs, 14 CCs, and 26 KEGG pathways. A PPI network with 187 nodes, 700 edges, and 2 modules, and another PPI network with 575 nodes, 2834 edges, and 7 modules were constructed based on the shared and specific DEGs, respectively. The top ten hub genes CCR3, CCR5, CXCL2, CXCL10, CXCR4, FPR1, APLNR, PENK, BDKRB2, GRM8, and RPS8, PRS3A, PRS12, RPS14, RPS21, RPL14, RPL18A, RPL21, RPL31 were identified for the shared and specific PPI networks, respectively. Conclusions: Our findings may help further the understanding of both shared and specific potential molecular mechanisms of ARVC and DCM.

31 July 2026 in Science Progress
Verified
Journal Article
Open access
YGYao-Zong Guan
Yao-Zong Guan
TZTang Zhang
Tang Zhang
HHHuan-Jie Huang
Huan-Jie Huang
DLDe-Sheng Lu
De-Sheng Lu
HLHao Liu
Hao Liu
Cardiac resynchronization therapy - defibrillator (CRT-D) is an effective treatment for ischemic heart failure (HF). But, it is a tricky challenge for left ventricular lead implantation difficulties during CRT-D. We report an ischemic cardiomyopathy patient with complete right bundle branch block (cRBBB) underwent CRT-D. During the implantation, the left anterior fascicular (LAF) region pacing was not ideal, and the implantation of left ventricular lead in lateral posterior or posterior wall was difficult. Then, leads were changed to be implanted into anterior septal region (near the LAF) and posterior septal region (near the LPF) from right ventricle, respectively. Synchronized pacing of LAB and LPB was performed to replace the pacing of left bundle branch region and left ventricular lateral posterior wall. Then, the QRS duration was shortened from 160ms to 100ms. During one month in follow-up, the patient’s quality of life was good and the pacing parameters were stable. This case illustrates a technically feasible, hypothesis-generating bailout approach for selected patients when conventional coronary sinus left ventricular lead placement and standard conduction system pacing are unsuccessful.